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Project Extension for Community Healthcare Outcomes (Project ECHO) offers an innovative and
low-cost approach to enhancing the management of complex conditions among primary care
providers. The NYC Health + Hospitals Buprenorphine ECHO (H+H ECHO) program offers
primary care providers (PCPs) training and support in managing opioid use disorder (OUD). This
exploratory study assessed the feasibility of a 16-session video conferencing platform led by
Addiction Medicine experts in improving addiction knowledge, perceived self-efficacy, and
buprenorphine prescribing among PCPs located in 17 publicly-funded ambulatory care clinics. A
pre- and post-training survey assessed changes in knowledge and self-efficacy. Buprenorphine
prescribing patterns were also captured pre-post training. Training sessions consisted of a review
of the agenda by the H+H ECHO hub team, 15–30 minute didactic lectures led by specialists,
followed by a patient case presentation. Participants attended an average of 9 lectures (range, 1–15
sessions) and 53% of trainees attended at least 10 of the 16 sessions. Perceived self-efficacy
improved post-H+H ECHO (73.2%) versus pre-training survey results (58.1%). There were
minimal increases in knowledge post-training (58.4%) versus pre-training (51.4%). Only three
additional providers reported prescribing Buprenorphine post-training (n=10) versus pre-training
(n=7). Suggestions for improving H+H ECHO included trainings addressing stigma,
administrative support, improved referrals to office-based opioid treatment (OBOT), integration of
non-physician staff (i.e., case management, social work), and combining multimodal learning
strategies (i.e., podcasts, web-based modules) with videoconferencing. This study demonstrates
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the feasibility of H+H ECHO among PCPs in publicly-funded clinics and improvements in selfefficacy. Studies are needed to identify alternative strategies to improve knowledge and prescribing
of buprenorphine post-H+H ECHO.
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1.

Introduction
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Opioid use disorder (OUD) remains a major public health burden. Differential uptake of
effective treatments for OUD in primary care persists, particularly in lower income, Black,
and Hispanic neighborhoods (Hansen et al., 2016). This disparity is further exacerbated by
provider-level barriers to prescribing buprenorphine in primary care, including concerns
about diversion, stigma, limited access to expert support, physician education, and
inadequate clinical support during induction (Andraka-Christou & Capone, 2018; Kermack
et al., 2017; Netherland et al., 2009).
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Expanding buprenorphine treatment in primary care may be facilitated by leveraging
emerging technologies (e.g., web-based modules, clinical decision support systems) that
reinforce clinical guidelines (Egan et al., 2010; Gunderson et al., 2006). Project ECHO
(Extension for Community Healthcare Outcomes) utilizes a “hub and spoke” model to
connect centralized experts and participating providers to facilitate didactic lectures and
case-based learning to enhance the delivery of care for a spectrum of health outcomes (e.g.,
OUD, Hepatitis C infection, pain management) (Komaromy et al., 2016; Zhou et al., 2016).
Sockalingam and colleagues utilized a Project ECHO model to significantly improve
primary care provider (PCP) knowledge of management of mental health and substance use
disorders (Sockalingam et al., 2018). In addition, Komaromy and colleagues described the
rapid expansion in buprenorphine-waivered PCPs in New Mexico following the Integrated
Addictions and Psychiatry (IAP) TeleECHO Clinic started in 2005 (Komaromy et al., 2016).
Despite these promising findings, further studies exploring PCP acceptability and
engagement with ECHO-based buprenorphine training to ensure improvements in
knowledge and buprenorphine prescribing post-training are needed.
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We evaluated the feasibility and potential effectiveness of the NYC Health + Hospitals
Buprenorphine ECHO (H+H ECHO) program by assessing: 1) PCP enrollment and
feedback to weekly trainings; 2) improvements in knowledge and self-efficacy based on prepost training responses; and 3) increases in buprenorphine prescribing following
participation in the H+H ECHO program.

2.
2.1.

Materials and methods
Sample and study sites
NYC Health + Hospitals is the largest public health system in the United States and includes
11 acute care hospitals and 18 Federally Qualified Health Center clinics. Since 2017, the
New York City Mayor’s Office, the Department of Health and Mental Hygiene, and NYC
J Subst Abuse Treat. Author manuscript; available in PMC 2020 November 01.
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Health + Hospitals leadership have bolstered funding and resources to address the opioid
overdose epidemic. NYC Health + Hospitals’ Buprenorphine ECHO program was launched
in May 2018 by the Health + Hospitals Office of Population Health, in partnership with the
Office of Behavioral Health, to enhance addiction education and accelerate the integration of
buprenorphine treatment in primary care. The H+H ECHO hub was located within the
Office of Population Health and addressed all aspects of H+H ECHO administration,
including logistics, communication, and technology. In addition to supervising the weekly
trainings, the hub paired participants with addiction specialist “mentors” across the Health +
Hospitals network to address trainee queries relating to managing patients with OUD via
telephone and email contact. The hub team organized a team of 3 specialists and 7 guest
lecturers with extensive clinical and/or research expertise in OUD to deliver lectures and
offer feedback to case discussions.
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The initial cohort consisted of one PCP from 17 of the 18 total H+H ambulatory care clinics
to ensure ubiquitous access to buprenorphine across the network. PCPs were invited to
participate in H+H ECHO via telephone calls and emails from the Office of Population
Health with clinic leadership. These providers agreed to complete DEA waiver training by
the end of the training, and be designated as site “champions” encouraging administrative
and clinical staff in their clinics to enhance the delivery of care for individuals with OUD.
Participants were encouraged by the H+H ECHO team to attend at least 10 of the 16
sessions between May 2018 – August 2018 and share clinical experiences pertaining to
buprenorphine treatment in the weekly sessions. The number of weekly sessions was based
on the ECHO learning model refined by the University of New Mexico ECHO Institute
(Komaromy et al., 2016). This study was reviewed and approved by the Institutional Review
Boards of the New York University School of Medicine, NYC Health + Hospitals, and the
Biomedical Research Alliance of New York.
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2.2.

Procedure
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The H+H ECHO program consisted of 16 weekly one-hour sessions. The Zoom
videoconferencing platform facilitated the video conferences and included a chat function to
update facilitators with questions or comments in real-time. Participants were emailed a
weekly agenda updating them on the training topic for that week and relevant journal
articles. Training sessions consisted of a review of the agenda by the H+H ECHO hub team
and a 15–30 minute didactic lecture led by a specialist, followed by a patient case
presentation. Cases were submitted by spoke sites, in advance of the session, and were
meant to elaborate on key points related to managing OUD and buprenorphine treatment and
elicit feedback from other participants on strategies and best practices in a variety of real
patient scenarios. The Poll Everywhere web- and text message system solicited participant
feedback and responses in real-time. Trainees received a post-session summary email, as
well as manuscripts pertaining to weekly training objectives.
2.3.

Project ECHO training
The design of the H+H ECHO training was based on Substance Abuse and Mental Health
Services Administration’s (SAMHSA) Treatment Improvement Protocol (TIP)
manuals(SAMHSA, 2018) guidance from the University of New Mexico ECHO
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Institute(Komaromy et al., 2016), a thorough review of the literature (Egan et al., 2010;
Komaromy et al., 2016; Sockalingam et al., 2018; Zhou et al., 2016), and additional
feedback by addiction medicine specialists. Curriculum topics were continuously revised per
participant feedback and consisted of 15–30 minute didactic lectures covering the following
topics: induction to buprenorphine; consent and accountability; urine toxicology; special
populations; stigma; buprenorphine management; office-based opioid treatment (OBOT)
quality improvement; safe opioid prescribing; criminally justice involved populations;
screening and tracking OUD; pain management; clinic and care management; technologybased interventions for OUD; motivational interviewing; and harm reduction. All trainees
were encouraged to complete their Drug Addiction Treatment Act of 2000 (DATA)
buprenorphine waiver training within 4 weeks after enrollment. Specialists included Internal
Medicine and Psychiatry physicians, with extensive experience in managing OUD and
prescribing buprenorphine in primary care.
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2.4.

Evaluation
Pre- and post-training surveys assessed knowledge (5-items) and self-efficacy (14-items),
and were based on items provided by the University of New Mexico ECHO Institute
(Komaromy et al., 2016). Open-ended questions assessed satisfaction with H+H ECHO
sessions and suggestions for improving trainings. Buprenorphine prescribing patterns were
captured from the electronic health record reports (i.e., Quadramed, EPIC) and analyzed per
prescriber. Descriptive statistics summarized clinician demographic characteristics, rates of
participation in H+H ECHO trainings, pre-post knowledge, and perceived self-efficacy.
Open-ended responses pertaining to suggestions for improving the training were reviewed
line-by-line to yield data clusters that were coded using an a priori coding scheme pertaining
to each emerging domain.
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3.

Results
Participants were mostly female (12/17), Black (4/17), Asian (4/17), or Hispanic/Latino
(2/17). Healthcare providers were board-certified in Internal Medicine or Family Medicine
(n=16) and included one Nurse Practitioner. Participants attended an average of 9lectures
(range, 1–15 sessions). Approximately half (53%) of participants attended at least 10 of the
16 sessions.
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PCPs demonstrated minimal improvements in knowledge in post-training survey results
(58.4%) versus pre-training (51.4%). The content area that did not yield improved
knowledge pertained to the duration of abstinence from short- and long-acting opioids prior
to induction on buprenorphine. Self-efficacy ratings among respondents increased at 16
weeks (73.2%) compared to pre-training (58.1%) results. Seven trainees were prescribing
buprenorphine one month preceding the training to a panel of 104 patients. Most PCPs were
prescribing buprenorphine (10/17) two months post-H+H ECHO training to a panel of 127
patients.
Suggestions for improving the didactic lectures included: additional training on pain
management; induction to buprenorphine; managing psychiatric comorbidities; overcoming
stigma among clinic staff; serving criminally justice involved populations with OUD;

J Subst Abuse Treat. Author manuscript; available in PMC 2020 November 01.

Tofighi et al.

Page 5

Author Manuscript

updates on more advanced urine toxicology tests; and technology-based interventions for
OUD. Trainees also requested didactic lectures on expanding social work and case
management involvement in OBOT, improving screenings and referrals from emergency
departments to primary care, and shifting negative perceptions of patients with OUD among
clinical staff. Overall feedback for improving the H+H ECHO program included archiving
recordings of video lectures, clinical shadowing of experienced buprenorphine providers,
and increasing the involvement of non-physician clinical staff.

4.

Discussion

Author Manuscript

The NYC Health + Hospitals Buprenorphine ECHO program offers a feasible approach to
deliver training pertaining to OUD and buprenorphine treatment. However, attendance varied
in weekly training sessions and may be attributed to the lack of reimbursement for time
allocated to lectures, unanticipated scheduling conflicts with clinic and administrative
responsibilities, or fading interest in managing OUD. Suggestions for improving
engagement in H+H ECHO sessions included multimodal learning strategies allowing
trainees to learn material through a variety of sensory modalities, including audio (e.g.,
podcasts) and/or visual (web-based modules) platforms. Trainees also cited increased
shadowing experiences with Addiction Medicine and Addiction Psychiatrists. Such peer-topeer connections may reduce feelings of professional isolation, facilitate the diffusion of
evidence-based practices by experienced providers, and deepen a sense of community
among providers.
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There were minimal improvements in knowledge and buprenorphine prescribing post- H+H
ECHO. PCP knowledge may be improved by utilizing multimodal training platforms (i.e.,
podcasts, web-based modules), case-based education, electronic notifications to improve
guideline-based management of OUD among trainees, and point-of-care training by pairing
participants with addiction medicine specialists during clinical encounters. Low rates of
buprenorphine prescribing may be attributed to inadequate screening and referral of patients
with OUD in tertiary- and primary care settings, negative treatment experiences among
patients with OUD in ambulatory care sites, or limited staff support facilitating
buprenorphine treatment (Andraka-Christou & Capone, 2018; Kermack et al., 2017;
Netherland et al., 2009). Further studies are needed to identify strategies and modifications
to the Project ECHO curriculum that will ensure high rates of prescribing among
buprenorphine providers post-training (Jones & McCance-Katz, 2018).

Author Manuscript

Lastly, requests for additional training on expanding the role of non-physician staff (i.e.,
social work, case management), addressing stigma among clinical staff, integrating
efficacious referral strategies to primary care, and adopting emerging technologies (e.g.,
smartphone applications, web-modules) underpin the importance of engaging providers in
performance improvement. These findings reflect emerging models of primary care that
increasingly emphasize task-shifting, patient education, patient-physician communication,
and operations management.(Goodall, 2011) Evidence now suggests that effective
“frontline” clinical leaders enhance clinical outcomes.(Bohmer, 2010) Further studies are
needed to assess whether ECHO trainings focusing on clinical leadership overcome systemsand provider-level barriers to addressing OUD and yield improved patient outcomes.
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Limitations to this exploratory study included: 1) the lack of generalizability of findings due
to inclusion of mostly physicians (16/17) located in New York City and only affiliated with
the Health + Hospitals network; 2) the small sample size and lack of a comparison group did
not allow for significance testing and detecting a true effect between the training and
primary outcomes; and 3) the need for longer-term assessments ensuring sustained effects of
the training (i.e., buprenorphine prescribing, retention of knowledge, and self-efficacy).

Conclusion
These findings suggest the feasibility of Project ECHO in enhancing perceived self-efficacy
among PCPs. However, improvements in knowledge and buprenorphine prescribing were
minimal post-training. These results will inform modifications to the NYC Health +
Hospitals Buprenorphine ECHO curriculum and the launch of a second cohort of providers.
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Highlights
Project ECHO enhanced perceived self-efficacy in managing opioid use disorder.
The number of physicians prescribing buprenorphine increased post-training.
Trainees demonstrated minimal improvements in knowledge in following the training
Post-training surveys yielded course-related feedback to improving Project ECHO.
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